The reverse split is a technical compliance measure — likely to address NYSE American minimum bid price requirements. Monitor for any subsequent equity offering or operational update, as reverse splits in micro-cap biotechs often precede capital raises.
Price Chart
Executive Summary
Matinas BioPharma filed a Certificate of Amendment to effect a 1-for-15 reverse stock split, effective September 28, 2026. The split consolidates every 15 outstanding common shares into 1 share, with fractional shares paid in cash, and does not change the authorized share count or par value. This is a mechanical capital structure adjustment aimed at regaining compliance with NYSE American listing standards, with no new financial data or operational catalysts disclosed.
Key Facts
- Reverse stock split ratio is 1-for-15, effective 12:01 a.m. ET on September 28, 2026.
- Authorized shares remain unchanged at 500 million common and 10 million preferred.
- No fractional shares issued; holders receive cash in lieu of fractional shares.
- Stockholders approved the amendment at the June 23, 2025 annual meeting; Board approved filing on September 16, 2026.
- CUSIP number changed to 576810 402.
- Trading on NYSE American on a split-adjusted basis expected to begin September 28, 2026, subject to exchange approval.
Financial Impact
No financial figures reported; reverse split is a mechanical share consolidation with no change to aggregate equity value.
Risk Factors
- Reverse splits can signal financial distress or listing non-compliance, potentially eroding investor confidence.
- Post-split stock may face selling pressure from retail holders exiting fractional positions.
- No operational or pipeline catalysts disclosed; the filing provides no update on drug development or financial performance.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-044451 |
| Exhibit: ex3-1.htm | 0001493152-26-044451 |
| Document: 0001493152-26-044451-index-headers.html | 0001493152-26-044451 |
| Document: 0001493152-26-044451-index.html | 0001493152-26-044451 |
| Document: 0001493152-26-044451.txt | 0001493152-26-044451 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 28, 2026 29d ago | 8-K | $2.53 $1.66 | ▼ −34.39% | ▼ −34.36% | $1.83 (−27.67%) |
Sep 16, 2026 5w ago | 8-K | $0.1630 $0.1613 | ▼ −1.02% | ▼ −2.23% | $1.83 (+1022.70%) |
Sep 4, 2026 7w ago | 8-K | $0.1820 $3.01 | ▼ −1553.85% | ▼ −1552.13% | $1.83 (−905.49%) |
Aug 25, 2026 9w ago | 425 | $0.1973 $0.1750 | ▲ +11.30% | ▲ +12.28% | $1.83 (−827.52%) |
Jul 30, 2026 12w ago | 425 | $0.3174 $0.2000 | ▲ +36.99% | ▲ +40.95% | $1.83 (−476.56%) |
Jul 24, 2026 13w ago | 8-K | $0.3320 $0.1965 | ▲ +40.81% | ▲ +44.11% | $1.83 (−451.20%) |
Jul 13, 2026 15w ago | 425 | $0.4800 $0.2690 | ▲ +43.96% | ▲ +47.14% | $1.83 (−281.25%) |
Jul 13, 2026 15w ago | 8-K | $0.4800 $0.2690 | ▲ +43.96% | ▲ +47.14% | $1.83 (−281.25%) |
Jun 26, 2026 17w ago | 8-K | $0.6640 $0.2414 | ▲ +63.64% | ▲ +63.37% | $1.83 (−175.60%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers